Robert Usaitis, DO | |
145 Hospital Ave, Suite 106, Du Bois, PA 15801-1462 | |
(814) 375-3910 | |
(814) 375-4424 |
Full Name | Robert Usaitis |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 29 Years |
Location | 145 Hospital Ave, Du Bois, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346266889 | NPI | - | NPPES |
001609890 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS-009308-L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Penn Highlands Community Nurses | St marys, PA | Home health agency |
Penn Highland Dubois | Dubois, PA | Hospital |
Penn Highlands Brookville | Brookville, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dubois Regional Medical Center | 5890689715 | 349 |
Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
News Archive
Researchers at the Stein Institute for Research on Aging at the University of California, San Diego have received a $4 million grant from the National Institute of Mental Health (NIMH), part of the National Institutes of Health, to study accelerated biological aging in schizophrenia.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan) would earn 30 percent patient share according to surveyed U.S. cardiologists
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.
› Verified 9 days ago
Entity Name | Dubois Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245410554 PECOS PAC ID: 5890689715 Enrollment ID: O20040426000432 |
News Archive
Researchers at the Stein Institute for Research on Aging at the University of California, San Diego have received a $4 million grant from the National Institute of Mental Health (NIMH), part of the National Institutes of Health, to study accelerated biological aging in schizophrenia.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan) would earn 30 percent patient share according to surveyed U.S. cardiologists
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.
› Verified 9 days ago
Entity Name | Brookville Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578733093 PECOS PAC ID: 3072579598 Enrollment ID: O20061115000235 |
News Archive
Researchers at the Stein Institute for Research on Aging at the University of California, San Diego have received a $4 million grant from the National Institute of Mental Health (NIMH), part of the National Institutes of Health, to study accelerated biological aging in schizophrenia.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan) would earn 30 percent patient share according to surveyed U.S. cardiologists
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Robert Usaitis, DO Po Box 447, Du Bois, PA 15801-0447 Ph: (814) 375-3910 | Robert Usaitis, DO 145 Hospital Ave, Suite 106, Du Bois, PA 15801-1462 Ph: (814) 375-3910 |
News Archive
Researchers at the Stein Institute for Research on Aging at the University of California, San Diego have received a $4 million grant from the National Institute of Mental Health (NIMH), part of the National Institutes of Health, to study accelerated biological aging in schizophrenia.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan) would earn 30 percent patient share according to surveyed U.S. cardiologists
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.
› Verified 9 days ago
Stanley Lang, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 190 W Park Ave, Suite 7, Du Bois, PA 15801 Phone: 814-375-1222 Fax: 814-375-9336 | |
Nina Lindemuth, CRNP Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Midway Dr, Du Bois, PA 15801 Phone: 814-299-7152 | |
Chun-yu Lee, Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200 | |
Dr. Kristin O'bryon Renwick, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 898 Beaver Dr, Du Bois, PA 15801 Phone: 814-371-3980 Fax: 814-371-8317 | |
Gregory Allan Sachs, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 529 Sunflower Dr, Du Bois, PA 15801 Phone: 814-375-0600 Fax: 814-375-4469 | |
Rene L Wells, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 90 Beaver Dr Bldg C, Du Bois, PA 15801 Phone: 814-317-2273 | |
Dr. Nicole Ignatius, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 90 Beaver Dr Ste 121d, Du Bois, PA 15801 Phone: 814-503-4837 Fax: 814-503-4697 |